Abstract
Survival of > or =5 years was seen in 8 of 153 patients (5%) with primary systemic amyloidosis and cardiac involvement. All patients with survival of >5 years received chemotherapy and all but 1 had an objective chemotherapeutic response.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Aged
-
Amyloidosis / mortality*
-
Amyloidosis / pathology
-
Biopsy
-
Cardiomyopathies / mortality*
-
Cardiomyopathies / pathology
-
Female
-
Humans
-
Male
-
Middle Aged
-
Myocardium / pathology
-
Survival Rate
-
Time Factors